U.S. Software Stock News

Organon & Co. ( NYSE:OGN ) shares have continued their recent momentum with a 25% gain in the last month alone. Not all...

Assurant recently appointed veteran asset management executive Lynn Blake, former Chief Investment Officer of Global Equity Beta Solutions at State Street, to its Board of Directors and launched F&I On Demand™, a virtual finance-and-insurance staffing solution for auto dealerships facing personnel and process challenges. Together, these moves highlight Assurant’s push to pair data-driven, technology-enabled services with experienced financial oversight, reinforcing its focus on specialized...

Nextpower (NXT) just posted its Q3 2026 scorecard, with revenue of US$909.4 million and basic EPS of US$0.88, alongside trailing twelve month revenue of about US$3.6 billion and EPS of US$4.03 that frame the latest quarter in a broader context. Over recent quarters, the company has seen revenue move from US$679.4 million in Q3 2025 to US$909.4 million in Q3 2026, while quarterly EPS has ranged from US$0.80 to US$1.08 across that period. This sets up a story where solid recent earnings are now...

Danaher (DHR) has just put fresh numbers on the table, with Q3 FY 2025 revenue of US$6.1 billion, basic EPS of US$1.28 and net income of US$908 million setting the tone for its latest update. The company has seen quarterly revenue move from US$5.7 billion in Q2 2024 to US$6.1 billion in Q3 2025. Over the same reported periods, basic EPS has ranged between about US$0.77 and US$1.50 as net income moved between US$555 million and US$1.09 billion. All of that now feeds into trailing twelve month...

If you are wondering whether Phibro Animal Health's current share price still offers value, this article walks through what the numbers are really saying about the stock. The share price closed at US$38.80, with returns of a 7.5% decline over the last 7 days, 2.8% over 30 days, 4.0% year to date, 80.0% over 1 year and 164.4% over 3 years, plus 101.2% over 5 years. Recent coverage has focused on Phibro Animal Health as part of wider discussions around animal health and pharmaceutical names,...

East West Bancorp, Inc. reported stronger fourth-quarter and full-year 2025 results, with higher net interest income of US$657.82 million and quarterly net income of US$356.27 million, alongside materially improved earnings per share versus the prior year. Alongside these results, the company sharply lifted its quarterly common dividend to US$0.80 per share and completed a multi-year buyback program that retired 7.38% of its shares, underscoring management’s willingness to return capital to...

Stock performance snapshot Park National (PRK) has drawn attention after recent share price moves, with the stock showing a mix of short term weakness and longer term gains that may prompt investors to reassess its latest financial profile. Over the past day, Park National’s share price reflected a 1.4% decline, adding to a 5.6% fall over the past week. By contrast, the stock shows a small gain over the past month and the past 3 months. For longer term holders, the picture is more mixed. The...

In recent weeks, Chord Energy has faced mixed analyst sentiment, with Citi downgrading the stock while other firms maintained more favorable ratings amid sector-wide macro concerns. At the same time, Chord Energy moved to expand its Williston Basin footprint through a US$550 million purchase of Exxon Mobil’s XTO Energy assets, signaling a material shift in its asset base and cash flow profile. We’ll now examine how this XTO Energy asset acquisition shapes Chord Energy’s investment narrative...

As the U.S. stock market experiences fluctuations driven by mixed corporate earnings and geopolitical uncertainties, investors are increasingly attentive to undervalued opportunities amidst the volatility. In such a climate, identifying stocks that may be trading below their estimated value can offer potential for growth, provided they exhibit strong fundamentals and resilience in challenging conditions.

As the U.S. stock market faces turbulence with major indices like the Dow Jones and S&P 500 experiencing declines, investors are keenly observing companies that exhibit resilience and potential for growth. In such a volatile environment, stocks of growth companies with high insider ownership often stand out as they suggest strong internal confidence in the business's future prospects.

As the U.S. market navigates a landscape marked by fluctuating tech stocks and record highs in precious metals, investors are increasingly looking beyond the well-trodden paths of major indices to uncover potential opportunities in lesser-known small-cap stocks. In this environment, identifying undiscovered gems requires a keen eye for companies with robust fundamentals that can withstand broader market volatility and capitalize on niche growth opportunities.

As the U.S. market faces fluctuations with major indices like the Dow Jones and S&P 500 experiencing declines, investors are increasingly seeking alternative opportunities to diversify their portfolios. Penny stocks, a term that may seem outdated, continue to hold potential for those willing to explore smaller or newer companies that can offer growth at lower price points. With strong balance sheets and solid fundamentals, these stocks can present hidden gems in today's market landscape,...

As the U.S. stock market navigates through a challenging period marked by declining tech shares and fluctuating precious metal prices, investors are increasingly seeking stability amid volatility. In such an environment, dividend stocks can offer a reliable income stream, providing both potential for growth and regular returns that may help cushion against market downturns.

Elevance Health (ELV) closed out FY 2025 with Q4 revenue of US$49.7b and basic EPS of US$2.47, alongside net income of US$547m. Over the past six quarters, the company has seen quarterly revenue move from US$45.1b in Q3 2024 to a range between US$48.9b and US$50.7b through 2025, while quarterly EPS shifted from US$4.38 to US$9.64 and then to US$2.47. This sets up an earnings print where margin resilience is front of mind for investors. See our full analysis for Elevance Health. With the...

Why the Renergen Helium Project Update Matters for ASP Isotopes (ASPI) ASP Isotopes (ASPI) has given investors a detailed production update on the newly acquired Renergen Helium Project, outlining higher gas throughput, completed plant upgrades, and a timetable toward positive operational cash flow before the end of 2026. See our latest analysis for ASP Isotopes. The Renergen update lands after a volatile stretch, with a 1-day share price return of 1.93% and a 7-day move of 8.77% helping...

Why Vaxart’s Norovirus Data Matters for Investors Vaxart (VXRT) has drawn fresh attention after npj Vaccines published Phase 1 data on its single dose, oral bivalent norovirus vaccine in postpartum, breastfeeding women, highlighting immune responses in both mothers and their infants. See our latest analysis for Vaxart. The new npj Vaccines publication comes after a strong 30 day share price return of 83.38% and 90 day share price return of 81.95%. However, the 1 year total shareholder return...

Curious whether Broadridge Financial Solutions at around US$204.89 is offering fair value or a potential bargain right now? This article walks through the numbers in a clear way so you can judge for yourself. The stock has seen mixed returns, with a 0.9% decline over the last 7 days, a 9.9% decline over the last 30 days and a 7.1% decline year to date. The 3 year and 5 year returns sit at 40.4% and 54.1% respectively, and the 1 year return is a decline of 11.6%. Recent coverage has focused...

First Busey (BUSE) has put a fuller year of numbers on the table for FY 2025, with fourth quarter revenue of US$197.8 million and EPS of US$0.63, rounding out trailing twelve month revenue of US$666.8 million and EPS of US$1.49. The company has seen revenue move from US$453.7 million and EPS of US$2.01 on a trailing basis in late 2024 to US$666.8 million and EPS of US$1.49 by the end of 2025. This is setting up a results season where investors are weighing those headline figures against a...

Travel + Leisure Co. has opened its new global headquarters at 501 W. Church St. in Downtown Orlando, relocating more than 900 associates and investing over US$36 million in a hybrid-friendly, wellness-focused workplace. The move deepens the company’s ties to Orlando’s urban core while expanding community engagement through the Travel + Leisure Charitable Foundation and local partnerships. We’ll now examine how this Orlando headquarters investment, especially its focus on a modern hybrid...

If you are wondering whether Corteva's current share price still offers value, it helps to step back and look at what the recent numbers and valuation checks are actually saying. Corteva's share price last closed at US$73.05, with returns of 2.2% over 7 days, 8.0% over 30 days, 7.8% year to date, 13.5% over 1 year and 17.2% over 3 years, plus 84.4% over 5 years. This naturally raises questions about how much of this is already reflected in the valuation. Recent news around Corteva has...

If you are wondering whether Icahn Enterprises at a last close of US$7.74 offers genuine value or just headline risk, you are not alone. This article is built to help you weigh that up clearly. The stock has been mixed recently, with a 6.0% return over 30 days and a 3.5% return year to date, set against a 2.4% decline over 1 year and much steeper 3 year and 5 year returns of 73.1% and 67.3% declines. These moves sit in the shadow of earlier scrutiny of Icahn Enterprises' structure and short...

In recent days, Travere Therapeutics disclosed that the FDA classified additional data for its FILSPARI sNDA as a major amendment, extending the review timeline and setting a new PDUFA action date of April 13, 2026, while multiple law firms announced investigations into potential securities law violations related to the company’s disclosures. This combination of a lengthened regulatory path for a key rare-disease therapy and parallel securities investigations adds an extra layer of...

Houlihan Lokey (NYSE:HLI) has expanded its European footprint with the hire of Mark Ward as Managing Director to lead IT Services coverage. The firm has also completed acquisitions in European real estate and corporate finance, adding sector depth and local capabilities. These moves reflect an active push to grow both organically and through acquisitions in key European markets. At a share price of $180.53, Houlihan Lokey has delivered a 3 year return of 94.8% and a 5 year return of 199.2%...

Lattice Semiconductor plans to deliver a keynote at FPGA-forum 2026 on AI expansion in FPGA applications. The company will showcase new edge AI and connectivity solutions built on its low power FPGA products. The event highlights Lattice Semiconductor's focus on AI-enabled hardware beyond its regular financial updates. Lattice Semiconductor (NasdaqGS:LSCC), trading at $84.84, is drawing attention not just for its share price but for its push into AI centric use cases. The stock has returned...